Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
about
Resveratrol in prostate diseases - a short reviewMultiple molecular targets of resveratrol: Anti-carcinogenic mechanismsUnraveling the Anticancer Effect of Curcumin and ResveratrolDietary polyphenols in prevention and treatment of prostate cancerKaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cellsPotential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signalingModifying Choroidal Neovascularization Development with a Nutritional Supplement in MiceResveratrol: French paradox revisited.Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway.Multifaceted ability of naturally occurring polyphenols against metastatic cancer.Therapeutic Potential of Resveratrol in Lymphoid Malignancies.Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas.Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells.
P2860
Q24601444-BAB9B727-B26A-4720-8F03-67101105C357Q24648759-15043438-3B9C-4027-B5C3-82068CC61708Q28073155-EF7B681D-2226-411B-A5D3-7C51EA5052CBQ28084787-3AE6EF3E-634D-449D-AE64-F652111CF787Q28535291-5D84FD28-83FD-4B29-BA1D-A1B5CEA57499Q34242787-F36CEBC0-C3E3-4EAE-8163-7015264FD191Q35080161-E15C34D9-2BFD-4FA0-9BF5-F5162DAF7042Q35685717-3915C9C0-A9AE-45C6-AD4B-05C1844E4CB6Q36099455-46EAA6C9-B9AE-4330-91B5-F05DA7D1055DQ38639579-7F877827-6800-43F8-B125-E2F867712548Q38698686-32FDD87E-DF13-4D60-A5C1-8EDEACB3E8ABQ38793825-632991BE-4E0C-4BE4-BFBE-CF4D0946133CQ39037806-D7C4E272-65E3-4193-82AF-2797DDA5DB23Q39315979-B568EF2C-E1F2-46F4-BDCD-16730B537201Q42255958-039B3994-1122-48B4-BA94-DAB5A44562CA
P2860
Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@ast
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@en
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@nl
type
label
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@ast
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@en
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@nl
prefLabel
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@ast
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@en
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@nl
P2093
P2860
P1476
Resveratrol as a novel agent f ...... roteinase inhibitory activity.
@en
P2093
Chun-yan Sun
Hua-fang Wang
Wen-juan He
Xiao-ping Zhang
P2860
P304
P356
10.1111/J.1745-7254.2006.00343.X
P577
2006-11-01T00:00:00Z
P5875
P6179
1025548133